ES420661A1 - Un procedimiento para la preparacion de sulfamoilfenil-imi-dazolidinonas. - Google Patents

Un procedimiento para la preparacion de sulfamoilfenil-imi-dazolidinonas.

Info

Publication number
ES420661A1
ES420661A1 ES420661A ES420661A ES420661A1 ES 420661 A1 ES420661 A1 ES 420661A1 ES 420661 A ES420661 A ES 420661A ES 420661 A ES420661 A ES 420661A ES 420661 A1 ES420661 A1 ES 420661A1
Authority
ES
Spain
Prior art keywords
sulphamoylphenyl
substituted
imidazolidinones
ones
imidazolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES420661A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Publication of ES420661A1 publication Critical patent/ES420661A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES420661A 1972-11-20 1973-11-19 Un procedimiento para la preparacion de sulfamoilfenil-imi-dazolidinonas. Expired ES420661A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5343772A GB1408010A (en) 1972-11-20 1972-11-20 Sulphamoylphenyl-imidazolidinones

Publications (1)

Publication Number Publication Date
ES420661A1 true ES420661A1 (es) 1976-04-01

Family

ID=10467808

Family Applications (1)

Application Number Title Priority Date Filing Date
ES420661A Expired ES420661A1 (es) 1972-11-20 1973-11-19 Un procedimiento para la preparacion de sulfamoilfenil-imi-dazolidinonas.

Country Status (21)

Country Link
US (1) US3963706A (en:Method)
JP (1) JPS541312B2 (en:Method)
AR (1) AR211379Q (en:Method)
AT (1) AT330766B (en:Method)
AU (1) AU470359B2 (en:Method)
BE (1) BE807490A (en:Method)
CA (1) CA1021783A (en:Method)
CH (3) CH603594A5 (en:Method)
DE (1) DE2357591C3 (en:Method)
DK (1) DK138645B (en:Method)
ES (1) ES420661A1 (en:Method)
FI (1) FI57934C (en:Method)
FR (1) FR2206947B1 (en:Method)
GB (1) GB1408010A (en:Method)
HU (1) HU170143B (en:Method)
IE (1) IE39319B1 (en:Method)
IL (1) IL43652A (en:Method)
NL (1) NL7315807A (en:Method)
PL (1) PL97758B1 (en:Method)
SE (1) SE417960B (en:Method)
ZA (1) ZA738824B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
EP1248625A2 (en) 1999-12-06 2002-10-16 Rhode Island Hospital Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors
YU52403A (sh) * 2000-12-26 2006-03-03 Dr.Reddy's Research Foundation Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
US7160912B2 (en) 2000-12-26 2007-01-09 Dr.Reddy's Laboratories Ltd. Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
CA2462564C (en) 2001-10-01 2012-07-10 Rhode Island Hospital Methods of inhibiting metastases
US20060293315A1 (en) * 2001-12-21 2006-12-28 Dr. Reddy's Laboratories Ltd. Intermediates of novel heterocyclic compounds having antibacterial activity and process for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1472625A (en:Method) * 1965-03-31 1967-05-24

Also Published As

Publication number Publication date
DK138645B (da) 1978-10-09
US3963706A (en) 1976-06-15
IL43652A (en) 1977-10-31
CH605808A5 (en:Method) 1978-10-13
CH603594A5 (en:Method) 1978-08-31
SE417960B (sv) 1981-04-27
CH605802A5 (en:Method) 1978-10-13
AU470359B2 (en) 1975-05-22
ZA738824B (en) 1974-09-25
DE2357591A1 (de) 1974-05-22
AU6266073A (en) 1975-05-22
HU170143B (en:Method) 1977-04-28
FI57934C (fi) 1980-11-10
DK138645C (en:Method) 1979-03-19
DE2357591B2 (de) 1979-07-05
JPS4993362A (en:Method) 1974-09-05
FR2206947B1 (en:Method) 1977-10-28
AR211379Q (es) 1977-12-15
DE2357591C3 (de) 1980-02-28
CA1021783A (en) 1977-11-29
IE39319L (en) 1974-05-20
IL43652A0 (en) 1974-03-14
ATA968773A (de) 1975-10-15
JPS541312B2 (en:Method) 1979-01-23
GB1408010A (en) 1975-10-01
NL7315807A (en:Method) 1974-05-22
FR2206947A1 (en:Method) 1974-06-14
BE807490A (fr) 1974-05-20
IE39319B1 (en) 1978-09-13
PL97758B1 (pl) 1978-03-30
FI57934B (fi) 1980-07-31
AT330766B (de) 1976-07-26

Similar Documents

Publication Publication Date Title
ES444044A1 (es) Procedimiento para la obtencion de derivados del acido pros-tanoico.
GB1151535A (en) Process for the Production of Nitrogenous Copolymers of Formaldehyde
ES420661A1 (es) Un procedimiento para la preparacion de sulfamoilfenil-imi-dazolidinonas.
CA996136A (en) Process for preparing urea
IE38553B1 (en) 2-aminomethyleneindanone analgesic agents
CS186221B2 (en) Ammonia synthesis convertor
ES442554A1 (es) Procedimiento para la obtencion de 1-metil-imidazoles.
CA1007232A (fr) Procedes de preparation de composes cyclises comportant un groupement uree
ES421879A1 (es) Procedimiento de preparacion de nuevas ciclopropilaminas.
ES418571A1 (es) Procedimiento para la preparacion de compuestos de 4 (lh)- pirimidinona.
ES419148A1 (es) Metodo para producir pivaloiloximetil d(-)- alfa-aminoben- cilpenicilinato cristalino.
JPS5414513A (en) Novel composition
ES381956A1 (es) Procedimiento para preparar derivados de ergolina.
JPS55147268A (en) Novel oxazolidine compound
GB1409993A (en) Antitussive
YU35008B (en) Process for preparing 5-(4-amino-3,5-dichloro-phenyl)-3-tert. butyl-oxazolidines
ES418746A1 (es) Procedimiento de preparacion de diacetona ceto-2 gulonato de calcio.
FR2268526A1 (en) Insoluble salts of cephalexin with amines - esp cephalexin benzatin - long acting antibiotics
ZA735583B (en) Nitrogenous fertilisers
FR2161597A5 (en) 1,4-dicyanobutene prepn - from tricyanobutane or methylene glutaronitrile
AU5342773A (en) Process for preparing urea
CA901010A (en) Process for the production of urea having a low carbamate content
CA916893A (en) Urea plant ammonia recovery system
CA912039A (en) Process for urea production in combination with ammonia synthesis
CA902890A (en) Process for the production of prilled urea having a low biuret content